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AbstrAct
The sixth annual report of the South African Renal Registry summarises the 2017 data on renal replacement 
therapy (RRT) for patients with end-stage renal disease (ESRD) in South Africa. In December 2017, the number of 
patients with ESRD who were treated with chronic dialysis or transplantation stood at 10 744, a prevalence of 190 
per million population (pmp). The growing prevalence observed since the registry was established is due mainly to 
the increasing numbers of patients accessing haemodialysis in the private sector, where the prevalence was 855 pmp. 
In the public sector, which serves 84% of the South African population, the prevalence of RRT (66 pmp) remained 
below the level reported for 1994, so that the disparity in access continued to increase. The disparities between 
provinces remained, with Limpopo and Mpumalanga the most under-served, as did the disparities between ethnic 
groups, with Blacks being the most under-served group. The Western Cape was the province with the highest public 
sector treatment rates and was also where most of the country’s public sector kidney transplants were performed.
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INtrODUctION 
The South African Renal Registry (SARR) collects, anal-
yses and publishes information on the treatment of 
patients with end-stage renal disease (ESRD) in South 
Africa on behalf of the South African Renal Society. This 
is the sixth consecutive annual report published by the 
SARR, which summarises the December 2017 data on 
renal replacement therapy (RRT) for patients with ESRD 
in South Africa.
MEtHODs
registry platform
Since the inception of the SARR, our technology platform 
has undergone several major iterations, all aimed at 
making data entry simpler and faster. Our current 
platform was developed using the Webdev programming 
environment (www.windev.com) and resides on a secure, 
dedicated, Windows 10 server at a leading South African 
internet hosting company. It runs Windows Internet 
Information Services (IIS) and uses the client/server 
version of HFSQL (formerly Hyperfile SQL) as its 
relational database management system. Data capturers 
interface with the central database via user-friendly web 
pages from any device that has internet access. Password 
protection ensures that treatment centres have access to 
their own data only. Data files are backed up daily using 
a specialist online backup company. Incremental backups 
of the registry application are also made daily and the full 
application is backed up weekly.
The quality of our data has improved considerably since 
we began cross-checking the identity numbers of our 
patients with the Department of Home Affairs database 
of births and deaths, which is accessible via the South 
African Medical Research Council. This has allowed us to 
analyse and report on the survival of our patients for the 
first time [1].
Improvements to the SARR platform are made con-
tinuously. For example, as a result of insights gained from 
recent data cleaning processes, we instituted several 
logical checks to prevent the entry of conflicting or 
implausible data and we improved the data dictionary.
Over the past few years, the technology platform of 
the SARR has been expanded to serve as the basis for 
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the newly established African Renal Registry. Botswana, 
Burundi, Ghana, Kenya and Zambia have formally joined 
the African Renal Registry and have started data collection 
with the aid of our platform [2,3].
Definitions
EsrD and start date of rrt. ESRD refers to advanced, 
irreversible, chronic kidney disease (CKD), which requires 
the initiation of RRT. The start date is the date of first 
haemodialysis (HD), the date of the first peritoneal dialysis 
(PD) flushes or exchanges, or the date of pre-emptive 
transplantation (where there is no prior dialysis). For 
patients who are initially thought to have acute kidney 
injury (AKI) and are dialysed but who do not recover 
function and then continue RRT, the start date is the date 
of the first dialysis, even though the diagnosis at that time 
was AKI and not ESRD.
Initial rrt modality. This is the intended first modality 
and should normally be the modality being used on day 91 
of RRT. This means that someone who presents late and 
who is started on urgent HD but is soon established on PD, 
will have PD recorded as the initial modality.
changes in the responsible treating unit. This refers 
to a change in the dialysis unit, PD follow-up unit/clinic, or 
transplant follow-up unit/centre/practice. A transfer entry 
in the registry is required to record this. This should not 
be done for short-term transfers when the intention is that 
the patient will return to the “home” unit, e.g. for holiday 
dialysis, temporary transfer to a unit with isolation facili- 
ties, etc.
Primary renal diagnosis. Responsible nephrologists/
physicians should assist their data-capturers to ensure that 
this critical information is accurate. We are using the set 
of renal diagnosis codes of the ERA-EDTA [4] and have 
mapped all previous entries to these codes. If there is 
uncertainty about the renal diagnosis, as is often the case 
with patients who present late, then the primary renal 
diagnosis should be indicated as “chronic kidney 
disease (cKD) – aetiology uncertain/unknown”. 
In patients who present with ESRD, small kidneys and 
hypertension there should not be an automatic default 
to labelling such patients as having “chronic glomeru-
lonephritis” or “hypertensive renal disease”.
chronic hypertensive nephropathy or malignant 
hypertensive nephropathy. This should be selected as 
the primary renal diagnosis only if there is no reason to 
suspect that the hypertension is secondary to pre-existing 
renal disease. We suggest that the following criteria be met: 
hypertension known to precede renal dysfunction, left 
ventricular hypertrophy, proteinuria < 2 g/day, and no evi-
dence of other renal diseases [5,6]. 
Lost to follow-up. The SARR assumes that a functioning 
transplant is maintained unless there is evidence of a 
“transplant failure” or death. A dialysis modality is assumed 
to continue for one year from the date of the last registry 
entry or laboratory result, in the absence of evidence of 
death; thereafter, the patient is considered lost to follow-
up. Patients are also considered lost to follow-up one 
year after a “transplant failure” entry if no further entries 
are recorded. 
recovered renal function. These are patients who 
have been initiated on chronic HD/PD and who no longer 
require dialysis. The period of dialysis-free recovery must 
persist for at least 90 days. If the period of recovery is less 
than 90 days and dialysis is restarted, there should be no 
END entry and dialysis is considered to have been con-
tinuous. If the period of recovery exceeds 90 days and 
the patient restarts RRT (even within the same year), 
there should be an END entry for the initial period of 
RRT and then a new entry recorded for the patient when 
he/she starts the second period of RRT, i.e., there will be 
two registry entries for the same patient.
Laboratory methods
Assays for serum albumin concentrations by the different 
laboratories all have reference ranges of 35–52 g/L. In the 
public sector, the National Health Laboratory Service 
(NHLS) uses the bromocresol green (BCG) method on 
Roche platforms. In the private sector, Lancet Laboratories 
uses BCG on Roche platforms, Ampath Laboratories uses 
BCG on Abbott ARCHITECT platforms, and PathCare 
uses BCG on Beckman platforms. 
Ethical approval
The SARR operates as a longitudinal study with ethical 
approval from the Health Research Ethics Committee of 
Stellenbosch University (reference no. N11/01/028). This is 
renewed annually upon submission of a progress report. A 
waiver of individual informed consent has been granted, 
and the approval includes countrywide data collection on 
adults and children, in the public and private sectors, and 
the tapping of various data sources to improve the accuracy 
and completeness of data. These include records available 
through doctors’ practices, dialysis and transplant centres, 
provider companies, and medical aid funds. Ethical approval 
has also been obtained for the use of the expanded SARR 
platform for the African Renal Registry.
rEsULts
south Africa in 2017
Figure 1 illustrates the provinces and major cities of South 
Africa. According to the Statistics South Africa (Stats SA) 
mid-year estimates for 2017 [7], the population of South 
Africa  had increased to 56.52 million people. The province 
of Gauteng was home to one-quarter of the population 
(Table 1). There was a slight female predominance (51.1%). 
Black/African citizens constituted 80.8% of the population, 
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table 2. population data by ethnic group.
population group Million %
Black 45.65 80.8
Coloured (mixed ancestry) 4.96 8.8
White 4.49 8.0
Indian/Asian 1.41 2.5
total 56.52 100
table 1. population data by province.
province Million %
Eastern Cape (EC) 6.50 11.5
Free State (FS) 2.87 5.1
Gauteng (GT) 14.28 25.3
KwaZulu-Natal (KZN) 11.07 19.6
Limpopo (LP) 5.78 10.2
Mpumalanga (MP) 4.44 7.9
North West (NW) 3.86 6.8
Northern Cape (NC) 1.21 2.1
Western Cape (WC) 6.51 11.5
total 56.52 100
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Figure 1. provinces and major cities of South Africa.
56.52 million
a small proportion (16%) having medical insurance and 
accessing private sector health care [8].
Life expectancy at birth for 2017 is estimated at 61.2 years 
for males and 66.7 years for females. The infant mortality 
rate is estimated at 32.8 per 1 000 live births. The overall 
HIV prevalence is approximately 12.6%, and is 18.0% for 
adults aged 15–49 [7].
with people of mixed ancestry (Coloured) making up 8.8%, 
Whites 8.0% and Indians/Asians 2.5% (Table 2).
South Africa is classified as an upper-middle-income 
country by the World Bank, with a GNI per capita for 2017 
by the Atlas method (current US$) of $5 410 and by the 
purchasing power parity (PPP) method (current inter-
national US$) of $13 060. Most of the population (84%) 
rely on the public healthcare sector for services, with only 
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treatment centres for dialysis and 
transplantation
The number of centres contributing data was 278; 249 
of these (89.6%) are privately owned (Table 3 and 
Appendix 1). Several provinces have increased access for 
their public sector patients by utilising spare capacity at 
private haemodialysis centres on a fee-per-treatment basis. 
There are also a few privately run centres on the premises 
of government hospitals which serve public sector patients.
Prevalence and incidence of renal 
replacement therapy
The total number of patients on RRT on 31 December 
2017 was 10 744. This is a prevalence of 190 per million 
population (pmp). The province with the highest patient 
numbers remained Gauteng, followed by the Western 
Cape and KwaZulu-Natal, whereas the province with the 
highest prevalence was the Western Cape, followed by 
Gauteng and the Free State (Figure 2).
There were 1 441 patients who started RRT in 2017, an 
incidence of 25 pmp. Most of these patients (84%) received 
RRT in private centres.
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table 3. Number of treatment centres by province and sector.
Sector ec fS Gt KZN lp Mp NW Nc Wc All
Public 3 6 6 5 0 0 3 1 5 29
Private 19 13 73 69 13 13 12 4 33 249
total 22 19 79 74 13 13 15 5 38 278
province ec fS Gt KZN lp Mp NW Nc Wc All
patients 1 013 578 3 608 2 064 391 254 424 129 2 283 10 744
Eastern Cape
Free State
Gauteng
KwaZulu-Natal
Limpopo
Mpumalanga
North West
Northern Cape
Western Cape
0 100 200 300
Prevalence (per million population)
400
156
202
253
186
68
57
110
106
351
Figure 2. prevalence and numbers of patients on RRt by province.
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The number of patients treated in the public sector remains 
low, with a prevalence of 66 pmp (Table 4). This was lower 
than the 70 pmp reported for 1994, when most of the 
chronic dialysis and transplantation was delivered in the 
public sector. In the private sector, the prevalence for 2017 
was 855 pmp. The numbers of patients and prevalences 
by province and healthcare sector are shown in Table 5 
and Figure 3. Denominators for prevalence calculations 
are based on the Stats SA mid-term estimates [7] and the 
Council for Medical Schemes Annual Report [8]. Medical aid 
beneficiaries who are unclassified with respect to province 
were allocated to provinces in proportion to the numbers 
of beneficiaries in each province..
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table 4. RRt prevalence by healthcare sector.
public private
Population in millions  47.65      8.87*
ESRD patients on treatment 3 162 7 582
Treatment rate (pmp)   66  855
*Council for Medical Schemes Annual Report 2017/18
table 5. Numbers of patients by sector and province.
Sector ec fS Gt KZN lp Mp NW Nc Wc All
Public 304 239 1 007 326 143 33 150 67 893 3 162
Private 709 339 2 601 1 738 248 221 274 62 1 390 7 582
total 1 013 578 3 608 2 064 391 254 424 129 2 283 10 744
Eastern Cape
Free State
Gauteng
KwaZulu-Natal
Limpopo
Mpumalanga
North West
Northern Cape
Western Cape
Public             Private
0 200 400 600 800 1 000 1 200 1 6001 400
52
1 109
97
869
94
721
33
1 380
27
591
9
392
44
586
65
334
172
1 040
Figure 3. prevalence of RRt by province and sector.
Prevalence (per million population)
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treatment modality and rrt vintage
Of the patients on RRT in December 2017, 17.3% had 
a functioning renal transplant. Of the patients on dialysis, 
13.5% were on peritoneal dialysis and 86.5% on haemo-
dialysis. Most of the transplant and peritoneal dialysis 
patients were in the public sector; the private sector 
had much lower proportions of patients on these RRT 
modalities (Figures 4 and 5).
Overall, the median RRT vintage was 4.4 years (inter-
quartile range (IQR) 2.1–7.5 years). The median vintage 
was 3.8 years (IQR 1.8–6.5 years) for haemodialysis 
patients, 3.5 years (IQR 1.6–6.3 years) for peritoneal 
dialysis patients and 8.1 years (IQR 5.4–12.5 years) for 
transplant patients.
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Figure 5. RRt modality by sector.
treatment modality
public sector private sector
patients % patients %
Haemodialysis 1 282 40.9 6 400 84.1
Peritoneal dialysis 814 26.0 385 5.1
Transplant 1 038 33.1 825 10.4
HD               PD               TX
puBlIc
40.9%
26.0%
33.1%
HD               PD               TX
pRIVAte
84.1%
5.1%
10.4%
Figure 4. distribution of patients by treatment modality.
Modality patients %
Haemodialysis 7 682 71.5
Peritoneal dialysis 1 199 11.2
Transplant 1 863 17.3
HD               PD               TX
2017
71.5%
11.2%
17.3%
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Data on new kidney transplants (Table 6) for 2017 were 
supplied by the South African Organ Donor Foundation 
(http://www.odf.org.za/). The number of transplants 
performed in 2017 was 260. The kidney transplant rate 
was 4.6 pmp. The bulk of the country’s transplants were 
performed in the provinces of Gauteng and the Western 
Cape. The Western Cape performed most of the public 
sector transplants; few were performed in KwaZulu-Natal 
and none in the Free State.
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table 6. New kidney transplants in 2017.
deceased donor living related living unrelated total
child Adult child Adult child Adult
Western Cape - Public 6 32 2 14 0 1 55
Western Cape - Private 0 13 0 28 0 14 55
Gauteng - Public 5 25 4 3 0 0 37
Gauteng - Private 1 36 5 21 0 20 83
 KwaZulu-Natal - Public  0  0  1 6 0 0 7
 KwaZulu-Natal - Private 0 7 0 6 0 3 16
 Free State - Public  0 0 0 0 0 0 0
 Free State - Private 0 4 0 1 0 2 7
total 12 117 12 79 0 40 260
Child = recipient <18 years; Adult = recipient 18 years and older.
The kidney transplant rate for 2017 was 4.6 pmp.  Data supplied by the SA Organ Donor Foundation.
Demographic and clinical data
The median age of the patients on RRT was 52.6 years 
(IQR 41.8–62.3 years) and 59.6% were male. Because of 
the rationing and selection criteria applied in public sector 
hospitals, patients treated there were much younger 
than those treated in the private sector (44.3 versus 55.9 
years). Just more than half of the patients were Black. 
However, the prevalence was still lowest in Blacks (126 
pmp) and highest in Indians/Asians (897 pmp) (Figure 6).
Figure 6. RRt patient numbers and prevalence by ethnicity.
Black            Coloured            Indian/Asian            White            Unknown/Other
ethNIcIty
51.7%
18.3%
2.1%
16.2%
11.7%
Black 
Coloured 
Indian/Asian 
White
0 200 400 600 800 1 000
126
354
897
442
Prevalence (per million population)
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The most commonly reported primary renal diagnosis 
was hypertensive renal disease, followed by CKD/ESRD of 
unknown cause and diabetic nephropathy (Table 7).
Of the patients with data on diabetes status (10 095 
patients), 38.7% had diabetes, with a much higher 
percentage in the private than in the public sector (50.1% 
versus 19.1%). The seropositive rate for hepatitis B virus 
was 2.2% (202 of 9 394 patients), for hepatitis C virus 0.8% 
(61 of 8 556 patients) and for HIV 10.8% (967 of 8 958 
patients).
DIscUssION
The number of patients on RRT in South Africa stood at 10 
744 in December 2017, a prevalence of 190 pmp. Most of 
the patients were being treated with haemodialysis in the 
private healthcare sector. There is still no evidence of any 
real growth in public sector access to RRT and treatment 
rates remained below those seen in 1994. The RRT 
prevalence in South Africa was very low when compared 
with other countries with similar or smaller gross national 
incomes per capita [9]. The Western Cape had the highest 
public sector treatment rates and was also the province 
where most of the public sector kidney transplants were 
performed. Access to transplantation for patients who rely 
on the public healthcare system was poor or non-existent 
in the rest of the country. The number of new patients 
starting RRT each year was also very low, and was the lowest 
of any country included in the International Comparisons 
chapter of the latest US Renal Data System report [9]. 
The Constitution of South Africa promises the progressive 
realisation of access to treatment [10]. However, this is not 
being achieved and remains a cause of great concern.
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table 7. Most commonly reported causes of eSRd.
% of total
Hypertensive renal disease 35.1
Cause unknown 31.9
Diabetic nephropathy 15.3
Glomerular disease 10.3
Cystic kidney disease 3.0
Obstruction and reflux 1.8
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APPENDIX 1: PArtIcIPAtING trEAtMENt cENtrEs
eASteRN cApe
public private private
Frere Hospital Jeffreys Bay Kidney and Dialysis Centre (FMC) NRC Mthatha
Livingstone Hospital Life Mercantile Hospital NRC Port Elizabeth HD
Nelson Mandela Academic Hospital Living Waters Dialysis Aliwal North NRC Port Elizabeth PD
NRC Butterworth NRC Queenstown
NRC East London HD NRC Uitenhage
NRC East London PD Port Elizabeth Kidney and Dialysis Centre (FMC)
NRC King Williamstown Regional Renal Services Lusikisiki
NRC Kwadwesi Regional Renal Services Matatiele
NRC Mdantsane Regional Renal Services Mthatha
fRee StAte
public private private
Boitumelo Regional Hospital (Kroonstad) B. Braun Avitum Bethlehem (Hoogland) NRC Bloemfontein HD
Bongani Regional Hospital (Welkom) B. Braun Avitum Bloemfontein NRC Bloemfontein PD
Dihlabeng Regional Hospital (Bethlehem) B. Braun Avitum Welkom NRC Kroonstad
Mofumahadi Manapo Mopeli Hospital (Qua Qua) Bloemfontein Kidney and Dialysis Centre (FMC) NRC Pelonomi
Pelonomi Regional Hospital Graham and Kolff Renal Therapy Thaba Nchu Sasolburg Kidney and Dialysis Centre (FMC)
Universitas Academic Hospital Life Rosepark Hospital Universitas Private Hospital
Living Waters Dialysis - Hoopstad unit
GAuteNG
public private private
Charlotte Maxeke Johannesburg Academic Hospital Arcadia Kidney and Dialysis Centre (FMC) Life The Glynnwood Hospital
Chris Hani Baragwanath Hospital Atteridgeville Kidney and Dialysis Centre (FMC) LRC Lenasia (Lenmed)
Dr George Mukhari Hospital B. Braun Avitum Emfuleni (Vanderbijlpark) LRC Lenasia South (Daxina)
Helen Joseph Hospital B. Braun Avitum Pretoria (Kloof) Mabika Renal Solutions
Leratong Hospital B. Braun Avitum Pretoria (Urology Hospital) Midstream Kidney and Dialysis Centre (FMC)
Steve Biko Academic Hospital B. Braun Avitum Sandton Morningside Children's Kidney Treatment Centre
B. Braun Avitum Vereeniging (Midvaal) Morningside Kidney and Dialysis Centre (FMC)
Carletonville Kidney and Dialysis Centre (FMC) Morula Kidney and Dialysis Centre (FMC)
Groenkloof Kidney and Dialysis Centre (FMC) Naledi Kidney and Dialysis Centre (FMC)
Harmelia Kidney and Dialysis Centre  (FMC) Nephromed Kidney Centre Kwa-Thema
Izinso Dialysis Busamed Netcare Transplant Centre Garden City Hospital
Izinso Dialysis Garankuwa Netcare Transplant Centre Jakaranda Hospital
Izinso Dialysis Soshanguve (Pretoria) Netcare Transplant Centre Milpark Hospital
Izinso Dialysis Soweto NRC Akasia
Kempton Kidney and Dialysis Centre (FMC) NRC Alberton
KwaMhlanga Dialysis Centre NRC Arcadia
Lenasia Kidney and Dialysis Centre (FMC) NRC Johannesburg PD
Lesedi Kidney and Dialysis Centre (FMC) NRC Krugersdorp
Life Bedford Gardens Hospital NRC Linksfield
Life Brenthurst Hospital NRC Lyttleton
Life Carstenhof Hospital NRC Mayfair
Life Fourways Hospital NRC Montana
Life Groenkloof Hospital NRC Mulbarton
Abbreviations:  FMC = Fresenius Medical Care, LRC = Lenmed Renal Centre, MRC = Melomed Renal Care, NRC = National Renal Care, RCH = Renal Care Holdings
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GAuteNG cont.
public private private
NRC Olivedale RCH Randfontein
NRC Parktown West RCH Zamokuhle (Thembisa)
NRC Pretoria East Renalworx Dialysis Centre Wilgers
NRC Pretoria PD Sunshine Dialysis Unit
NRC Rynfield Tshepo-Themba Kidney and Dialysis Centre (FMC)
NRC Sebokeng Tshwane Kidney and Dialysis Centre (FMC)
NRC Sedibeng Vaal Kidney and Dialysis Centre (FMC)
NRC Sunninghill Vosloorus Kidney and Dialysis Centre (Clinix)
NRC Sunward Park Waverley Kidney and Dialysis Centre (FMC)
NRC Thabazimbi Westrand Dialysis Westonaria 
NRC Waterfall Westrand Kidney and Dialysis Centre (FMC)
Pretoria Kidney and Dialysis Centre (FMC) Wits Donald Gordon Kidney and Dialysis Centre (FMC)
Randfontein Kidney and Dialysis Centre (FMC) Wits Donald Gordon Medical Centre Transplant Division
Randfontein Private Hospital Dialysis Unit
KWAZulu-NAtAl
public private private
Addington Hospital B. Braun Avitum Dundee NRC Athlone
Greys Hospital B. Braun Avitum Durdoc NRC Ballito
Inkosi Albert Luthuli Hospital B. Braun Avitum Ethekwini NRC Berea
King Edward VIII Hospital B. Braun Avitum Newcastle NRC Chatsworth
Ngwelezana Hospital B. Braun Avitum Pietermaritzburg NRC Durban PD
B. Braun Avitum Scottburgh NRC Gateway
B. Braun Avitum Vryheid NRC Greyville
Chatsworth Kidney and Dialysis Centre (FMC) NRC Hillcrest
Coastal Nephrology Centre Greytown NRC Ladysmith
Coastal Nephrology Centre Nongoma NRC Margate
Coastal Nephrology Centre Pongola NRC Pietermaritzburg CBD
Coastal Neprology Centre Ulundi NRC Pietermaritzburg PD
Dr Parag and Raghubir Kidney Care Centre NRC Pinetown
Durban Kidney and Dialysis Centre (FMC) NRC Richards Bay
Ekuphileni Renal Centre Manguzi NRC Umhlanga
Empangeni Kidney and Dialysis Centre (FMC) Pinetown Kidney and Dialysis Centre (FMC)
Entabeni Kidney and Dialysis Centre (FMC) Port Shepstone Kidney and Dialysis Centre (FMC)
Ethekwini Kidney and Dialysis Centre (FMC) RCH Ladysmith
Hibiscus Kidney and Dialysis Centre (FMC) RCH Shifa
Kokstad Kidney and Dialysis Centre (FMC) Regional Renal Services Harding
Kwazulu Dialysis Randles Renal Unit (Sparks) Regional Renal Services Ixopo
Kwazulu Dialysis Umlazi Megacity Renal Unit Renal Care Team Durdoc
Kwazulu Dialysis Westville Renal Unit Renal Care Team Kwamashu
 KZN Nephrology and Dialysis Clinic Renal Care Team Ladysmith
Life Chatsmed Hospital Renal Care Team Pinetown
Life Empangeni Hospital Richards Bay Kidney and Dialysis Centre (FMC)
Life Entabeni Hospital Sparks Renal Unit
Life Hilton Hospital Stanger Kidney and Dialysis Centre (FMC)
Life Mount Edgecombe Hospital Ultra Kidney Care City Hospital
Merediac Durban Ultra Kidney Care Isipingo
Midlands Dialysis and Kidney Centre Umhlanga Kidney and Dialysis Centre (FMC)
Mount Edgecombe DCG Verulam Dialysis Centre
Mount Edgecombe Kidney and Dialysis Centre (FMC) Victoria Kidney and Dialysis Centre (FMC)
Netcare Transplant Centre St Augustine’s Hospital Vryheid Kidney and Dialysis Centre (FMC)
Newcastle Kidney and Dialysis Centre (FMC)
Abbreviations:  FMC = Fresenius Medical Care, LRC = Lenmed Renal Centre, MRC = Melomed Renal Care, NRC = National Renal Care, RCH = Renal Care Holdings
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lIMpopo
public private private
B. Braun Avitum Louis Trichardt Nephromed Kidney Centre Elim 
B. Braun Avitum Mokopane NRC Polokwane
B. Braun Avitum Polokwane NRC Venda
B. Braun Avitum Tzaneen Phalaborwa Kidney and Dialysis Centre (FMC)
Chantel van Rooyen Bela-Bela Polokwane Kidney and Dialysis Centre (FMC)
Edison Giyani Centre Thohoyandou Kidney and Dialysis Centre (FMC)
Edison Thohoyandou Centre
MpuMAlANGA
public private private
B. Braun Avitum Ermelo Highveld Nephrology Center
B. Braun Avitum Nelspruit Life Midmed Hospital
B. Braun Avitum Trichardt Middelburg Kidney and Dialysis Centre (FMC)
B. Braun Avitum Witbank NRC Nelspruit
Edison Lebowakgomo Centre Supreme Dialysis Malelane 
Emalahleni Kidney and Dialysis Centre (FMC) Supreme Dialysis Standerton
Hazyview Dialysis Centre
NoRth WeSt
public private private
Job Shimankana Tabane Hospital B. Braun Avitum Vryburg North West Dialysis Lichtenburg
Klerksdorp Hospital Brits Kidney and Dialysis Centre (FMC) North West Dialysis Viljoenskroon
Mafikeng Hospital Izinso Dialysis Mafikeng NRC Rustenberg
Living Waters Dialysis Klerksdorp Potchefstroom Kidney and Dialysis Centre (FMC)
Mafikeng Kidney and Dialysis Centre (FMC) Rustenburg Kidney and Dialysis Centre (FMC)
North West Dialysis Klerksdorp Zeerust Renal Unit
NoRtheRN cApe
public private private
Kimberley Hospital B. Braun Avitum Kimberley North West Dialysis Hartswater
B. Braun Avitum Upington RCH Kimberley 
WeSteRN cApe
public private private
George Hospital Athlone Kidney and Dialysis Centre (FMC) NRC Cape Town CBD
Groote Schuur Hospital B. Braun Avitum Cape Gate NRC Cape Town PD
Red Cross War Memorial Children's Hospital B. Braun Avitum Mossel Bay NRC George
Tygerberg Hospital B. Braun Avitum Oudtshoorn NRC Goodwood
Worcester Hospital B. Braun Avitum Worcester NRC Kuilsriver
Cape Town Kidney and Dialysis Centre (FMC) NRC Paarl
George Kidney and Dialysis Centre (FMC) NRC Plumstead
Hermanus Kidney and Dialysis Centre (FMC) NRC Vredenburg
Khayelitsha Kidney and Dialysis Centre (FMC) Paardevlei Kidney and Dialysis Centre (FMC)
Life Vincent Pallotti Hospital Panorama Kidney and Dialysis Centre (FMC)
Life Vincent Pallotti Hospital Paediatrics Rondebosch Dialysis Centre
MRC Gatesville HD Stellenbosch Kidney and Dialysis Centre (FMC) 
MRC Gatesville PD UCT Kidney and Dialysis Centre (FMC)
MRC Mitchells Plain UCT Private Academic Hospital
MRC Tokai Winelands Kidney and Dialysis Centre (FMC)
Netcare Transplant Centre Christiaan Barnard 
Memorial Hospital
Worcester Kidney and Dialysis Centre (FMC)
NRC Blaauwberg
Abbreviations:  FMC = Fresenius Medical Care, LRC = Lenmed Renal Centre, MRC = Melomed Renal Care, NRC = National Renal Care, RCH = Renal Care Holdings
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fRee StAte
public private
Universitas Private Hospital
GAuteNG
public private
Charlotte Maxeke Johannesburg Academic Hospital Netcare Garden City Hospital
Steve Biko Academic Hospital Netcare Jakaranda Hospital
Netcare Milpark Hospital
Wits Donald Gordon Medical Centre
KWAZulu-NAtAl
public private
Inkosi Albert Luthuli Hospital Life Entabeni Hospital
Netcare St Augustine’s Hospital
WeSteRN cApe
public private
Groote Schuur Hospital Netcare Christiaan Barnard Memorial Hospital 
Red Cross War Memorial Children's Hospital UCT Private Academic Hospital
Tygerberg Hospital
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